Apelin-APJ effects of ginsenoside-Rb1 depending on hypoxia-induced factor 1α in hypoxia neonatal cardiomyocytes

Chinese Journal of Integrative Medicine

Volumn 21, Issue 2, 2015, Pages 139-146

  Kong, Hong liang ^a   Li, Zhan quan ^a   Zhao, Shu mei ^b   Yuan, Long ^a   Miao, Zhi lin ^a   Liu, Ying ^a   Guan, Ru ming ^a  

^a People's Hospital of Liaoning Province   (China)

^b SHENYANG NORMAL UNIVERSITY   (China)

Author keywords

apelin; APJ; cardiomyocytes; ginsenosides Rb1; hypoxia; hypoxia induced factor 1

Indexed keywords

APLN PROTEIN, RAT; APLNR PROTEIN, RAT; G PROTEIN COUPLED RECEPTOR; GINSENOSIDE; GINSENOSIDE RB 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; SIGNAL PEPTIDE;

ANIMAL; CARDIAC MUSCLE CELL; CELL HYPOXIA; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NEWBORN; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CELL HYPOXIA; GINSENOSIDES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCYTES, CARDIAC; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER;

EID: 84939875899     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-014-1774-2     Document Type: Article

References (39)

1. Liu YF, Liu SW, Liu ZX. Effects of ginsenoside Rb1 on blood vessel regeneration after ischemia and reperfusion in rats. Chin J Histochem Cytochem (Chin) 2008;17:39–44.
2. Zeng HS, Liu ZX. Influence of ginsenoside Re on cardiomyocyte apoptosis and Fas expression after acute ischemia-reperfusion in rats. J Huazhong Univ Sci Tech (Health Sci, Chin) 2004;33:286–288.
3. Guan L, Li WZ, Liu ZX. Effect of ginsenoside-Rb1 on cardiomyocyte apoptosis after ischemia and reperfusion in rats. J Huazhong Univ Sci Technol (Med Sci, Chin) 2002;22:212–215.
4. Liu ZX, Liu XC. Effect of ginsenoside Rb1 and Re on cardiomyocyte apoptosis after ischemia and reperfusion in rats. Chin J Histochem Cytochem (Chin) 2002;11:374–377,506.
5. Kong HL, Wang JP, Li ZQ, Zhao SM, Dong J, Zhang WW. Anti-hypoxic effect of ginsenoside Rb1 on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo. Acta Pharmacol Sin (Chin) 2009;30:396–403.
6. 2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening. Acta Pharmacol Sin (Chin) 2010;31:687–695.
7. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004;118:119–125.
8. Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 2005;126:233–240.
9. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003;108:1432–1439.
10. Barnes G, Japp AG, Newby DE. Translational promise of the apelin-APJ system. Heart 2010;96:1011–1016.
11. Pitkin SL, Maguire JJ, Kuc RE, Davenport AP. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol 2010;160:1785–1795.
12. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail 2008;10:725–732.
13. Quazi R, Palaniswamy C, Frishman WH. The emerging role of apelin in cardiovascular disease and health. Cardiol Rev 2009;17:283–286.
14. Ronkainen VP, Ronkainen JJ, Hänninen SL, Leskinen H, Ruas JL, Pereira T, et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007;21:1821–1830.
15. Han S, Wang G, Qi X, Lee HM, Englander EW, Greeley GH Jr. A possible role for hypoxia-induced apelin expression in enteric cell proliferation. Am J Physiol Regul Integr Comp Physiol 2008;294:R1832–R1839.
16. Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, et al. HIF-1 regulates hypoxia- and insulininduced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab 2007;293:E1590–E1596.
17. Zhang Z, Yu B, Tao GZ. Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. Chin Med J 2009;122:2360–2365.
18. Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, Tang CS. Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 2009;30:1144–1152.
19. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol 2007;102:518–528.
20. Lee S, Chanoit G, McIntosh R, Zvara DA, Xu Z. Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol Heart Circ Physiol 2009;297:H569–H575.
21. Miyamoto S, Murphy AN, Brown JH. Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. J Bioenerg Biomembr 2009;41:169–180.
22. Yao Y, Li L, Li L, Gao C, Shi C. Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion. Biol Pharm Bull 2009;32:1854–1861.
23. Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, Sollott SJ. Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 2009;104:1240–1252.
24. Miura T, Miki T. GSK-3beta, a therapeutic target for cardiomyocyte protection. Circ J 2009;73:1184–1192.
25. Petrosillo G, Colantuono G, Moro N, Ruggiero FM, Tiravanti E, Di Venosa N, et al. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 2009;297:H1487–H1493.
26. Yue P, Jin H, Xu S, Aillaud M, Deng AC, Azuma J, et al. Apelin decreases lipolysis via G(q), G(i), and AMPKdependent mechanisms. Endocrinology 2011;152:59–68.
27. Yue P, Jin H, Aillaud M, Deng AC, Azuma J, Asagami T, et al. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 2010;298:E59–E67.
28. Masri B, Lahlou H, Mazarguil H, Knibiehler B, Audigier Y. Apelin (65–77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 2002;290:539–545.
29. Kleinz MJ, Baxter GF. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept 2008;146:271–277.
30. Zhu W, Zou Y, Aikawa R, Harada K, Kudoh S, Uozumi H, et al. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. Circulation 1999;100:2100–2107.
31. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000;86:692–699.
32. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002;16:1151–1162.
33. Zhou YF, Zheng XW, Zhang GH, Zong ZH, Qi GX. The effect of hypoxia-inducible factor 1-alpha on hypoxiainduced apoptosis in primary neonatal rat ventricular myocytes. Cardiovascular J Africa 2010;21:37–41.
34. Keränen MA, Nykänen AI, Krebs R, Pajusola K, Tuuminen R, Alitalo K, et al. Cardiomyocyte-targeted Hif-1alpha gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat. J Heart Lung Transplant 2010;29:1058–1066.
35. Date T, Mochizuki S, Belanger AJ, Yamakawa M, Luo Z, Vincent KA, et al. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. Am J Physiol Cell Physiol 2005;288:C314–C320.
36. 2 tension. Proc Natl Acad Sci USA 1995;92:5510–5514.
37. Sun HL, Liu YN, Huang YT, Pan SL, Huang DY, Guh JH, et al. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia. Oncogene 2007;26:3941–3951.
38. Kim HL, Yeo EJ, Chun YS, Park JW. A domain responsible for Hif-1α degradation by YC-1, a novel anticancer agent. Int J Oncol 2006;29:255–260.
39. Lau CK, Yang ZF, Lam CT, Tam KH, Poon RT, Fan ST. Suppression of hypoxia inducible factor-1α (Hif-1α) by YC-1 is dependent on murine double minute 2 (Mdm2). Biochem Biophys Res Commun 2006;348:1443–1448.